Family Medicine · Amarillo, TX
NPI
1861405250
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2501 Lakeview Dr
Amarillo, TX, 79109
Phone (806) 350-8277
Groups this clinician bills Medicare through
Medicare paid, 2024
$178K
2,789 services
Medicare patients, 2024
1,050
Average age 79
Drug cost, 2024
$3.4M
62,696 prescriptions
Company payments, 2025
$26K
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ron K Rankin was code 99232 (hospital e&m - subsequent), 844 times for 281 patients. In total Ron K Rankin billed 2,789 services in 47 codes, and Medicare paid $178K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 844 | 281 | $59.42 | $50K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 297 | 284 | $40.22 | $12K |
| 99223 Hospital E&M - Initial | Facility | 270 | 244 | $130.09 | $35K |
| 99309 SNF E&M | Facility | 242 | 174 | $80.95 | $20K |
| 99309 SNF E&M | Office | 214 | 166 | $76.79 | $16K |
| 99233 Hospital E&M - Subsequent | Facility | 181 | 112 | $87.02 | $16K |
| 36415 Venipuncture Blood Collection | Office | 124 | 82 | $8.65 | $1,073 |
| 99308 SNF E&M | Facility | 122 | 107 | $56.16 | $6,851 |
| 99222 Hospital E&M - Initial | Facility | 48 | 48 | $96.79 | $4,646 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 47 | 26 | $29.39 | $1,381 |
| 99310 SNF E&M | Facility | 38 | 37 | $110.20 | $4,188 |
| 99308 SNF E&M | Office | 24 | 22 | $53.24 | $1,278 |
| 87426 Immunoassay | Office | 19 | 18 | $34.62 | $658 |
| 81002 Clinical Chemistry | Office | 16 | 15 | $3.41 | $54.56 |
| G0008 Administration of influenza virus vaccine | Office | 14 | 14 | $23.24 | $325 |
By year: 2022 $99K for 1,936 services; 2023 $86K for 1,758 services; 2024 $178K for 2,789 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 124 | 82 | $8.65 | $1,073 |
| 87426 Immunoassay | 19 | 18 | $34.62 | $658 |
| 81002 Clinical Chemistry | 16 | 15 | $3.41 | $54.56 |
Medicare prescription drug claims, 2024
In 2024, the drug Ron K Rankin prescribed most often to Medicare patients was Potassium Chloride, with 2,894 prescriptions and refills. In total Ron K Rankin wrote 62,696 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Potassium Chloride Generic | 2,894 | 2,910 | 416 | $62K |
| Atorvastatin Calcium Generic | 2,654 | 2,673 | 336 | $34K |
| Levothyroxine Sodium Generic | 2,422 | 2,472 | 307 | $30K |
| Furosemide Generic | 2,376 | 2,381 | 322 | $18K |
| Eliquis Apixaban | 2,004 | 2,024 | 189 | $639K |
| Gabapentin Generic | 1,933 | 1,955 | 250 | $29K |
| Amlodipine Besylate Generic | 1,773 | 1,804 | 240 | $18K |
| Pantoprazole Sodium Generic | 1,561 | 1,584 | 212 | $23K |
| Lisinopril Generic | 1,300 | 1,313 | 188 | $14K |
| Carvedilol Generic | 1,137 | 1,154 | 153 | $12K |
| Sertraline Hcl Generic | 1,062 | 1,073 | 153 | $14K |
| Duloxetine Hcl Generic | 1,000 | 1,016 | 111 | $21K |
| Donepezil Hcl Generic | 982 | 991 | 141 | $16K |
| Clopidogrel Clopidogrel Bisulfate | 948 | 950 | 118 | $12K |
| Losartan Potassium Generic | 937 | 947 | 139 | $13K |
Brand drugs: 8,629 claims; generic drugs: 53,939 claims; opioid claims: 2,222.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ron K Rankin $26K ($26K in general payments such as food, travel and fees) from 2 companies. The largest payer was Kedplasma LLC with $26K.
| Company | Payments | Amount |
|---|---|---|
| Kedplasma LLC | 18 | $26K |
| Neurocrine BioSciences, Inc. NBIX | 1 | $22.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.